NTAN1P3

Across TCGA pan-cancer cohorts, NTAN1P3 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of NTAN1P3’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where NTAN1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NTAN1P3 is over-expressed in tumor.

THCA, BRCA, and HNSC are the cancer types where NTAN1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NTAN1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.386	<.001	7	view →
BRCA	Female	All	+0.093	<.001	6	view →
HNSC	All	All	+0.052	.005	6	view →
KICH	All	All	+0.366	.003	5	view →
BLCA	All	All	+0.074	.026	5	view →
LUSC	Female	III,IV	+0.135	.001	3	view →
KIRC	Male	II,III,IV	+0.031	.027	3	view →
LUAD	Female	II,III,IV	+0.076	.006	2	view →
STAD	All	II,III,IV	+0.056	.030	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

NTAN1P3–THCA

Open the THCA breakdown →